MPLT
NASDAQ · Biotechnology
Maplight Therapeutics Inc
$6.93
+0.71 (+11.41%)
Open$6.24
Previous Close$6.22
Day High$6.93
Day Low$6.06
52W High$40.43
52W Low$6.19
Volume—
Avg Volume328.3K
Market Cap345.68M
P/E Ratio—
EPS$-12.54
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+811.8% upside
Current
$6.93
$6.93
Target
$63.19
$63.19
$44.21
$63.19 avg
$83.67
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 110.57M | 109.60M | 110.00M |
| Net Income | -5,057,192 | -4,807,023 | -6,303,306 |
| Profit Margin | -4.6% | -4.4% | -5.7% |
| EBITDA | -7,551,548 | -8,325,034 | -7,754,101 |
| Free Cash Flow | -7,533,825 | -4,832,804 | -6,604,673 |
| Rev Growth | +23.3% | +7.4% | -2.1% |
| Debt/Equity | 0.30 | 0.38 | 0.35 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |